Journal of Medical Economics, Volume 19, Issue 10 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 19, Issue 10 (2016)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Volume 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Oncology

Article
The real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu-positive early breast cancer in Taiwan
Hui-Chu Lang, Hsiao-Wei Chen, Tzeon-Jye Chiou & Agnes L. F. Chan
Pages: 923-927
Published online: 18 May 2016
AbstractforThe real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu-positive early breast cancer in Taiwan | Full Text | References | PDF (799.1 KB)
  • 1655 Views
  • 20 CrossRef citations
  • 0Altmetric
Free Access

Virology

Article
Healthcare resource utilization and costs associated with herpes zoster in the US
Barbara H. Johnson, Liisa Palmer, Justin Gatwood, Gregory Lenhart, Kosuke Kawai & Camilo J. Acosta
Pages: 928-935
Published online: 21 May 2016
AbstractforHealthcare resource utilization and costs associated with herpes zoster in the US | Full Text | References | PDF (838.7 KB)
  • 1149 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Respiratory

Article
Cost-effectiveness of ceritinib in patients previously treated with crizotinib in anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer in Canada
Manjusha Hurry, Zheng-Yi Zhou, Jie Zhang, Chenxue Zhang, Liangyi Fan, Mayvis Rebeira & Jipan Xie
Pages: 936-944
Published online: 25 May 2016
AbstractforCost-effectiveness of ceritinib in patients previously treated with crizotinib in anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer in Canada | Full Text | References | PDF (1.1 MB)
  • 1580 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden
Sara Olofsson, Hanna Norrlid & Ulf Persson
Pages: 945-958
Published online: 31 May 2016
AbstractforPreferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden | Full Text | References | PDF (1.3 MB)
  • 606 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article
Cost comparison of radiofrequency catheter ablation versus cryoablation for atrial fibrillation in hospitals using both technologies
Tina D. Hunter, Swetha R. Palli & John A. Rizzo
Pages: 959-964
Published online: 17 May 2016
AbstractforCost comparison of radiofrequency catheter ablation versus cryoablation for atrial fibrillation in hospitals using both technologies | Full Text | References | PDF (758.5 KB) | Supplemental
  • 1794 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data
Chakkarin Burudpakdee, Huamao Mark Lin, Weiying Wang, Arpamas Seetasith, Yanyan Zhu, Vijayveer Bonthapally & Kenneth R. Carson
Pages: 965-972
Published online: 26 May 2016
AbstractforClinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data | Full Text | References | PDF (960.1 KB)
  • 728 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Cost of severe hypoglycaemia in nine European countries
Michał Jakubczyk, Izabela Lipka, Justyna Pawęska, Maciej Niewada, Elżbieta Rdzanek, Jelka Zaletel, Antonio Ramírez de Arellano, Tomáš Doležal, Biljana Chekorova Mitreva, Bence Nagy, Guenka Petrova, Tereza Šarić, John Yfantopoulos & Marcin Czech
Pages: 973-982
Published online: 03 Jun 2016
AbstractforCost of severe hypoglycaemia in nine European countries | Full Text | References | PDF (917.2 KB)
  • 2870 Views
  • 22 CrossRef citations
  • 0Altmetric
Free Access

Hepatology

Article
Economic evaluation of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic genotype 1 hepatitis c virus infection
Scott J. Johnson, Hélène Parisé, Suchin Virabhak, Ivana Filipovic, Jennifer C. Samp & Derek Misurski
Pages: 983-994
Published online: 30 May 2016
AbstractforEconomic evaluation of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic genotype 1 hepatitis c virus infection | Full Text | References | PDF (1.6 MB) | Supplemental
  • 654 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
A cost-utility analysis of prolonged-release tacrolimus relative to immediate-release tacrolimus and ciclosporin in liver transplant recipients in the UK
Gorden Muduma, Isaac Odeyemi & Richard F. Pollock
Pages: 995-1002
Published online: 01 Jun 2016
AbstractforA cost-utility analysis of prolonged-release tacrolimus relative to immediate-release tacrolimus and ciclosporin in liver transplant recipients in the UK | Full Text | References | PDF (1.1 MB)
  • 864 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article
A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States
Sephy Philip, Sumita Chowdhury, John R. Nelson, P. Benjamin Everett, Carolyn K. Hulme-Lowe & Jordana K. Schmier
Pages: 1003-1010
Published online: 15 Jul 2016
AbstractforA novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States | Full Text | References | PDF (694.1 KB)
  • 780 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
The economic value of INTUITY in aortic valve replacement
Matthew Moore, Glenn R. Barnhart, Walter Randolph Chitwood Jr, John A. Rizzo, Candace Gunnarsson, Swetha R. Palli & Eugene A. Grossi
Pages: 1011-1017
Published online: 23 Aug 2016
AbstractforThe economic value of INTUITY in aortic valve replacement | Full Text | References | PDF (900.6 KB)
  • 550 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Nephrology

Editorial
Dialysis: the best quality at the lowest cost
Mabel Aoun
Pages: 1018-1019
Published online: 24 Aug 2016
CitationforDialysis: the best quality at the lowest cost | Full Text | References | PDF (177.9 KB)
  • 603 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Intensive care unit improves dialysis care quality while reducing costs
Tara Greenleaf Nichols et al.
Research Letter | Published online: 7 Jun 2024
Open Access
The efficiency of TAVI in intermediate and low-risk Japanese patients
Panagiotis Petrou
Editorial | Published online: 7 Jun 2024
Open Access
Analysis of long-term clinical and cost impact of etranacogene dezaparvovec for the treatment of hemophilia B population in the United States
Songkai Yan et al.
Article | Published online: 6 Jun 2024
Open Access
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar et al.
Article | Published online: 6 Jun 2024
Open Access
View all latest articles